Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

GABAergic deficits and schizophrenia-like behaviors in a mouse model carrying patient-derived neuroligin-2 R215H mutation.

Jiang DY, Wu Z, Forsyth CT, Hu Y, Yee SP, Chen G.

Mol Brain. 2018 Jun 1;11(1):31. doi: 10.1186/s13041-018-0375-6.

2.

Neuroligin 2 R215H Mutant Mice Manifest Anxiety, Increased Prepulse Inhibition, and Impaired Spatial Learning and Memory.

Chen CH, Lee PW, Liao HM, Chang PK.

Front Psychiatry. 2017 Nov 27;8:257. doi: 10.3389/fpsyt.2017.00257. eCollection 2017.

3.

Neuroligin 2 nonsense variant associated with anxiety, autism, intellectual disability, hyperphagia, and obesity.

Parente DJ, Garriga C, Baskin B, Douglas G, Cho MT, Araujo GC, Shinawi M.

Am J Med Genet A. 2017 Jan;173(1):213-216. doi: 10.1002/ajmg.a.37977. Epub 2016 Nov 16.

PMID:
27865048
4.

Practical Experience of the Application of a Weighted Burden Test to Whole Exome Sequence Data for Obesity and Schizophrenia.

Curtis D; UK10K Consortium.

Ann Hum Genet. 2016 Jan;80(1):38-49. doi: 10.1111/ahg.12135. Epub 2015 Oct 16.

5.

Neuroligin 2 deletion alters inhibitory synapse function and anxiety-associated neuronal activation in the amygdala.

Babaev O, Botta P, Meyer E, Müller C, Ehrenreich H, Brose N, Lüthi A, Krueger-Burg D.

Neuropharmacology. 2016 Jan;100:56-65. doi: 10.1016/j.neuropharm.2015.06.016. Epub 2015 Jun 30.

PMID:
26142252
6.

Dystroglycan binding to α-neurexin competes with neurexophilin-1 and neuroligin in the brain.

Reissner C, Stahn J, Breuer D, Klose M, Pohlentz G, Mormann M, Missler M.

J Biol Chem. 2014 Oct 3;289(40):27585-603. doi: 10.1074/jbc.M114.595413. Epub 2014 Aug 25.

7.

Hippocampal neuroligin-2 overexpression leads to reduced aggression and inhibited novelty reactivity in rats.

Kohl C, Riccio O, Grosse J, Zanoletti O, Fournier C, Schmidt MV, Sandi C.

PLoS One. 2013;8(2):e56871. doi: 10.1371/journal.pone.0056871. Epub 2013 Feb 22.

8.

Rare exonic deletions implicate the synaptic organizer Gephyrin (GPHN) in risk for autism, schizophrenia and seizures.

Lionel AC, Vaags AK, Sato D, Gazzellone MJ, Mitchell EB, Chen HY, Costain G, Walker S, Egger G, Thiruvahindrapuram B, Merico D, Prasad A, Anagnostou E, Fombonne E, Zwaigenbaum L, Roberts W, Szatmari P, Fernandez BA, Georgieva L, Brzustowicz LM, Roetzer K, Kaschnitz W, Vincent JB, Windpassinger C, Marshall CR, Trifiletti RR, Kirmani S, Kirov G, Petek E, Hodge JC, Bassett AS, Scherer SW.

Hum Mol Genet. 2013 May 15;22(10):2055-66. doi: 10.1093/hmg/ddt056. Epub 2013 Feb 7.

PMID:
23393157
9.

Developmental delays and reduced pup ultrasonic vocalizations but normal sociability in mice lacking the postsynaptic cell adhesion protein neuroligin2.

Wöhr M, Silverman JL, Scattoni ML, Turner SM, Harris MJ, Saxena R, Crawley JN.

Behav Brain Res. 2013 Aug 15;251:50-64. doi: 10.1016/j.bbr.2012.07.024. Epub 2012 Jul 20.

10.

Identification and functional characterization of rare mutations of the neuroligin-2 gene (NLGN2) associated with schizophrenia.

Sun C, Cheng MC, Qin R, Liao DL, Chen TT, Koong FJ, Chen G, Chen CH.

Hum Mol Genet. 2011 Aug 1;20(15):3042-51. doi: 10.1093/hmg/ddr208. Epub 2011 May 6.

11.

Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia.

Gauthier J, Siddiqui TJ, Huashan P, Yokomaku D, Hamdan FF, Champagne N, Lapointe M, Spiegelman D, Noreau A, Lafrenière RG, Fathalli F, Joober R, Krebs MO, DeLisi LE, Mottron L, Fombonne E, Michaud JL, Drapeau P, Carbonetto S, Craig AM, Rouleau GA.

Hum Genet. 2011 Oct;130(4):563-73. doi: 10.1007/s00439-011-0975-z. Epub 2011 Mar 22.

Supplemental Content

Loading ...
Support Center